Tag: medicinal drugs
Mislabelled products: legal rights for compensation
Anyone who has been harmed as a result of mislabelled products could be entitled to bring a claim for compensation, and we can offer No Win, No Fee legal representation for eligible clients.
As Group Action Lawyers, this is the kind of event that we can represent people for. Not all incidents of the incorrect information on products can lead to harm but, when it does, this is where we may be able to help anyone affected.
Mass medical negligence claims for compensation
Mass medical negligence claims for compensation can be the important avenue for some form of justice when a person is harmed as a result of avoidable negligence.
We have advised and represented a lot of people for these kinds of legal cases, and we are proud to offer No Win, No Fee legal representation as part of our commitment to access to justice. The specialist team is here to listen to you if you need free, no-obligation advice about existing claims or new class actions.
You could be owed tens of thousands of pounds in damages, so make sure you step forward to claim what you could be owed.
Sterility problems and compensation actions
Anyone who has been adversely affected by sterility problems could be entitled to pursue a claim for personal injury compensation on a No Win, No Fee basis.
As a firm of specialist Group Action Lawyers, we have represented many victims for issues concerning the sterility of equipment and devices, and there have been plenty of regulatory recalls over the years where this has been the issue.
A single event or a prolonged problem where an issue over sterility occurs could lead to thousands of people being put at risk. Anyone who has ever suffered harm in this way could be entitled to pursue a claim for damages.
Compensation for medicine recalls
You can be entitled to claim compensation for medicine recalls if you have suffered some form of harm or injury arising from an issue with medicines that you have taken.
If something has gone wrong and the fault lies with the manufacturer, seller, or even someone administering medicine, you could be entitled to pursue a legal case. We can offer No Win, No Fee legal representation, and you can speak to the team here for free, no-obligation advice.
Commissioner to champion people harmed by medicines or medical devices
In a huge win for anyone harmed by medicines or medical devices, the government has agreed to the appointment of an Independent Patients’ Commissioner. Their role will be to stand up for people who have fallen victim to the dangerous side-effects of certain medical products.
At The Group Action Lawyers, we have been raising the unheard voices of suffering patients for many years, taking on many clients in large group and multi-party actions against powerful medical companies and manufacturers. As such, we welcome the news of this new public service, which represents a significant step in the right direction for patients and overall safety.
Rise in anti-depressants prescriptions for children
The reported rise of anti-depressants prescriptions for children could be a cause for concern, particularly when the use of anti-depressants is not generally recommended by the NHS for under 18’s.
Recent figures reportedly show over 1,500 children under the age of 5 were prescribed anti-depressants, with the numbers reaching over 91,000 for 16-year olds.
Any recent reported rise in anti-depressants prescriptions for children could be partially attributed to the outbreak of the coronavirus pandemic in March. Many people, children included, have struggled to receive professional mental health services as the waiting times are so long. With the NHS staff under further pressure to cope during the pandemic, many surgeries and treatments have seen pauses and delays as resources are directed elsewhere.
Drugs recall compensation claims advice
Drugs recall compensation claims can form into group and multi-party actions when users have suffered as a result of a problem with the manufacturers or the suppliers.
The impact for the victims in these kinds of cases can, of course, be severe; especially if the drugs being recalled are for serious or even life-threatening conditions. Even the fact that there is a recall can be worrying for the patients who are told to stop taking their medication and seek replacements.
When these kinds of recalls happen, they can lead to group action compensation claims if the impact on the victims is severe enough. Groups could range from just a small number of victims who were unlucky enough to be affected, to thousands of people who may have suffered.
Patient information leaflet errors
Patient information leaflet errors can, in the worst-case scenarios, cause severe problems for those who have used the wrong medication or used meds incorrectly due to the error.
When these scenarios happen, a recall will usually be launched and announced via the Medicines and Healthcare products Regulatory Agency (MHRA). Information about the recall will normally be distributed so that patients can be made aware, but this won’t always stop an adverse incident from occurring.
With this in mind, here’s a little advice about what to do if you have suffered harm as a result of following the incorrect information for medication or a product in general.
Xarelto compensation settlements
Big news! Xarelto compensation settlements are taking place, with almost £600m in damages set to be paid out by Bayer AG and Johnson & Johnson.
The settlements are for around 25,000 lawsuits in the U.S., where Bayer and J&J have reportedly agreed to settle the litigation for $775m. The Group Action Lawyers continue to fight for justice for UK victims who are suffering side-effects of taking the drug, that’s also known as Rivaroxaban. You can read more about the UK action here.
While the companies maintain that the claims are without merit, and the settlement is made without an admission of liability, this is a huge result. The two companies are set to be sharing the burden of the cost as they jointly-developed the drug.
Valsartan recall widens
The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).
Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued after the discovery that some Valsartan products were contaminated. Legal cases are already underway, and this latest recall involves further batches of the product.
An immediate suspension and quarantine of the additional affected products has been ordered.